Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2012
12/05/2012CN102805868A Method of treatment using ligand-immunogen conjugates
12/05/2012CN102805867A Application of transcription factor NFATC3 as drug target in reversing multidrug resistance of tumor
12/05/2012CN102805861A Lactate dehydrogenase A acetylation activator and application thereof
12/05/2012CN102805860A Inhibitor for acetylation of pyruvate kinase 2 (PKM2) and use thereof
12/05/2012CN102805859A Method of producing recombinant tat-hoxb4h protein for use as a stimulant of hematopoiesis in vivo
12/05/2012CN102805858A High-efficiency calcium supplement capsule and preparation method thereof
12/05/2012CN102805857A Preparation method of compound amino acid (15) dipeptide (2) injecta
12/05/2012CN102335418B Health-care wine for relieving rheumatoid swelling
12/05/2012CN102178960B Application of Tap73 gene in preparation of cancer stem cell chemosensitization medicine
12/05/2012CN102120031B Pharmaceutical compositions and methods for accelerating wound healing
12/05/2012CN102085358B Application of medicament containing hirudin, hementerin and hyaluronidase
12/05/2012CN102085357B Purpose of medicine adopting hirudin and hementerin as raw materials
12/05/2012CN102078603B Medicine with action of treating cardiovascular and cerebrovascular diseases
12/05/2012CN102028939B Medicine with hirudin-containing active ingredient
12/05/2012CN102028938B Medicament having effects of activating blood and dissolving stasis
12/05/2012CN101972481B Macromolecular microcarrier and preparation method thereof
12/05/2012CN101918018B Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
12/05/2012CN101890152B Application of Chinese yam glycoprotein in preparation of antihypoxic and antifatigue medicaments
12/05/2012CN101631800B Canine thymic stromal lymphopoietin protein and uses thereof
12/05/2012CN101590229B Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
12/05/2012CN101367869B Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same
12/05/2012CN101189261B High affinity melan-A t cell receptors
12/05/2012CN101175860B Cellulases, nucleic acids encoding them and methods for making and using them
12/05/2012CN101087619B Method of treatment or prophylaxis
12/04/2012US8324386 Somatostatin-dopamine chimeric analogs
12/04/2012US8324370 Interfering RNA molecules
12/04/2012US8324362 Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors
12/04/2012US8324348 Evaluation of copolymer diethylamide
12/04/2012US8324347 Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry
12/04/2012US8324346 Bioactive keratin peptides
12/04/2012US8324344 Membrane transduction peptides and methods of delivering material to a target cell
12/04/2012US8324176 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
12/04/2012US8324175 Compositions and methods for the treatment of cancer
12/04/2012US8324174 Compounds for enzyme inhibition
12/04/2012US8324173 Peptides useful as dual caspase-2/-6 inhibitors and their biological applications
12/04/2012US8324172 G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same
12/04/2012US8324171 Ophthalmic compositions containing diglycine
12/04/2012US8324170 Interferon gamma receptor beta chain compositions and methods of inhibiting apoptosis
12/04/2012US8324169 VEGF-activated ligands
12/04/2012US8324168 Methods for treating pain
12/04/2012US8324167 Treatment of T-cell mediated diseases
12/04/2012US8324166 Neuroprotection using NAP-like and SAL-like peptide mimetics
12/04/2012US8324165 Compositions for treating arthritis comprising HG1023575 polypeptide
12/04/2012US8324164 Peptides and altered peptide ligands derived from HSP60 and pharmaceutical compositions
12/04/2012US8324162 Diuretic and natriuretic polypeptides lacking the blood pressure lowering property
12/04/2012US8324161 Leukotriene B4 binding soluble lipocalin receptor from ixodes ricinus
12/04/2012US8324160 Chimeric polypeptides and uses thereof
12/04/2012US8324159 Erythropoietin receptor peptide formulations and uses
12/04/2012US8324158 Methods for inhibiting CLC-2 channel with GATX2
12/04/2012US8324157 Preparation comprising insulin, nicotinamide and an amino acid
12/04/2012US8324156 Oral insulin therapies and protocol
12/04/2012US8324155 Quinoxaline-containing compounds as hepatitis C virus inhibitors
12/04/2012US8324154 Treatment of fungal infections with cyclic antimicrobial peptides
12/04/2012US8324153 Antiviral cell-penetrating peptides
12/04/2012US8324152 Composition for the treatment of atherosclerosis
12/04/2012US8324151 Treatment of sepsis and septic shock using ghrelin and growth hormone
12/04/2012US8324150 Cell-proliferation inhibiting VPg proteins, fragments or analogs thereof and their applications
12/04/2012US8324149 Encapsidation of heterologous entities into virus-like particles
12/04/2012US8324148 Delivering to the subject a compound comprising a nuclear localization sequence of NF-kB such that nuclear importation of NF-kB is inhibited
12/04/2012US8323964 proteolytic fragment of a growth differentiation factor (GDF) polypeptide (pro-GDF) or a functional peptide portion thereof; affects activity associated with GDF signal transduction
12/04/2012US8323962 Molecules with extended half-lives, compositions and uses thereof
12/04/2012US8323918 Chloroacetamidine based inhibitors and activity based probes for the protein arginine methytransferases
12/04/2012US8323902 Methods for producing soluble membrane-spanning proteins
12/04/2012US8323884 Isolated SNARE YKT6 genomic polynucleotide fragments from chromosome 7 and their uses
12/04/2012US8323794 Injectable hydrogel microspheres from aqueous two-phase system
12/04/2012US8323689 Solid oral dosage form containing an enhancer
12/04/2012US8323688 Pharmaceutical compositions comprising hGH for oral delivery
12/04/2012US8323679 Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
12/04/2012US8323665 Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin
12/04/2012US8323659 Method for diagnosing and/or treating tumor
12/04/2012US8323656 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof
12/04/2012US8323649 Antibodies to IL-6 and use thereof
12/04/2012US8323648 Methods of modulating and identifying agents that modulate intracellular calcium
12/04/2012US8323643 Methods for treating adhesive capsulitis
12/04/2012US8323642 Using metalloproteinase mixture to enhance healing of ligament tissues
12/04/2012US8323641 Nanoparticulate compositions having lysozyme as a surface stabilizer
12/04/2012US8323640 Highly functional enzyme having α-galactosidase activity
12/04/2012US8323638 Methods and compositions for tissue regeneration
12/04/2012US8323636 Long-acting interferons and derivatives thereof and methods thereof
12/04/2012US8323635 Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
12/04/2012US8323615 Methods of processing multi-phasic dispersions
12/04/2012CA2629304C Combination of glycoisoforms for the treatment or prevention of septicemia, transgenic cell line that produces erythropoietin glycoisoforms, pharmaceutical composition comprising said combination
12/04/2012CA2575768C Method for screening toxin neutralizing peptide, stx2 inhibiting peptide and verotoxin neutralizing agent
12/04/2012CA2573479C Effective use method of medicaments and method of preventing expression of side effect
12/04/2012CA2572743C Methods for improving bioavailability of a renin inhibitor
12/04/2012CA2557914C Use of botulinum toxin for preparing a drug for preventing hair growth
12/04/2012CA2537748C Use of telmisartan for the prevention of vascular headache
12/04/2012CA2521177C Use of a botulinum neurotoxin to alleviate various disorders
12/04/2012CA2515745C Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
12/04/2012CA2501282C Vasoregulating compounds and methods of their use
12/04/2012CA2474798C Method and composition for treatment of inflammation and aids-associated neurological disorders
12/04/2012CA2463879C Glycoprotein compositions
12/04/2012CA2443345C Disease-associated protein
12/04/2012CA2430582C A method for in vitro molecular evolution of protein function
12/04/2012CA2428834C Biodegradable poly(beta-amino esters) and uses thereof
12/04/2012CA2422294C Modulation of il-2- and il-15-mediated t cell responses
12/04/2012CA2400868C Anti-egfrviii scfvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
12/04/2012CA2349442C Compositions and methods for wt1 specific immunotherapy
12/04/2012CA2261630C Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease
12/04/2012CA2246033C Therapeutic agent for herniated intervertebral disc
1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 3163